ArticleMedicina (Kaunas, Lithuania)2026
The Impact of Concurrent Proton Pump Inhibitors on Nivolumab Response in Metastatic Non-Small Cell Lung Cancer: A Multicenter Real-Life Study.
Engin Hendem, Mehmet Zahid Koçak, Ayşegül Merç Çetinkaya, Gülhan Dinç, Melek Çağlayan, Muzaffer Uğraklı, Dilek Çağlayan, Murat Araz, Melek Karakurt Eryılmaz, Abdullah Sakin and 4 more
Abstract readMulticenter Study
In one paragraphArticle in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Engin HendemDepartment of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42080, Turkey.ORCID 0000-0001-6970-4733 Mehmet Zahid KoçakDepartment of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42080, Turkey.ORCID 0000-0003-3085-7964 Ayşegül Merç ÇetinkayaDepartment of Medical Oncology, School of Medicine, Akdeniz University, Antalya 07070, Turkey.ORCID 0000-0003-2727-7387 Gülhan DinçDepartment of Medical Oncology, Prof. Dr. Cemil Taşcıoğlu City Hospital, İstanbul 34384, Turkey.ORCID 0009-0007-6025-7800 Melek ÇağlayanDepartment of Medical Oncology, School of Medicine, Selcuk University, Konya 42130, Turkey.ORCID 0000-0002-6043-4703 Muzaffer UğraklıDepartment of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42080, Turkey.ORCID 0000-0003-0544-6047 Dilek ÇağlayanDepartment of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42080, Turkey.ORCID 0000-0003-4629-6815 Murat ArazDepartment of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42080, Turkey.ORCID 0000-0002-4632-9501 Melek Karakurt EryılmazDepartment of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42080, Turkey.ORCID 0000-0003-2597-5931 Orhan Önder ErenDepartment of Medical Oncology, School of Medicine, Selcuk University, Konya 42130, Turkey.ORCID 0000-0001-6397-8207 Ali Murat TatlıDepartment of Medical Oncology, School of Medicine, Akdeniz University, Antalya 07070, Turkey.ORCID 0000-0001-9696-1102 Çağlayan GeredeliDepartment of Medical Oncology, Prof. Dr. Cemil Taşcıoğlu City Hospital, İstanbul 34384, Turkey.ORCID 0000-0002-3982-7465 Mehmet ArtaçDepartment of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42080, Turkey.ORCID 0000-0003-2335-3354 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoma, Non-Small-Cell LungLung NeoplasmsNivolumabProton Pump InhibitorsAgedAged, 80 and overAntineoplastic Agents, ImmunologicalDrug InteractionsFemaleHumansImmune Checkpoint InhibitorsKaplan-Meier EstimateMaleMiddle AgedRetrospective StudiesAntineoplastic Agents, ImmunologicalImmune Checkpoint InhibitorsNivolumabProton Pump InhibitorsCarcinomadrug interactionsmicrobiotanivolumabnon-small-cell lungoverall survivalprogression-free survivalproton pump inhibitors
Identifiers
PMID41597500
PMCPMC12843493
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390